Page 1658 - Clinical Small Animal Internal Medicine
P. 1658
1596 Index
congestive heart failure (CHF) (cont’d) corticosteroids head trauma 752–753
VetBooks.ir feline myocardial disease 267, gastritis and gastric ulceration 549 nystagmus 738
neurologic assessment 735–739
canine inflammatory liver
271, 273
disease 699–700, 703
palpebral fissure and third eyelid 737
left‐sided 131–132, 134, 136–137
management 185–197 hemotropic Mycoplasma 929 strabismus 737–738
right‐sided 132 metabolic bone diseases 1517 vestibular disease 789–790
sodium and water miscellaneous skin vision ‐ menace and
homeostasis 1071 diseases 1498–1500 pupils 736–737
valvular heart disease 246–250 neuromuscular junction craniomandibular osteopathy
conjunctiva 1261–1262 diseases 806 (CMO) 1548–1549
consciousness 448, 753 respiratory pattern‐based approach CRCoV see canine respiratory
constant rate infusion (CRI) to dyspnea 291 coronavirus
acute poisoning 444 septic shock 425, 428 CRE see carbapenem‐resistant
cardiogenic shock 418 spinal cord injury 745 Enterobacteriaceae
fluid therapy 363 venomous snake bites 464 C‐reactive protein (CRP) 633
phosphorus homeostasis and corticotroph cell marker 51 creams 1398, 1469
disorders 1083 corticotrophy differentiation creatine kinase (CK) 461, 812
trauma and burns 451 markers 51 creatinine 1165, 1166
venomous snake bites 464 corticotropin‐releasing hormone CRH see corticotropin‐releasing
constipation 572, 575–580, 612–613 (CRH) 50, 81 hormone
constrictive pericarditis 284–285 cortisol 30, 30, 81, 84–85 CRI see constant rate infusions
diagnosis 284–285 cortisol‐to‐ACTH ratio (CAR) 84 cricopharyngeal chalasia 474
etiology/pathophysiology 284 cotton‐tipped applicator cricopharyngeal dysphagia 474
history and clinical signs 284 smears 1391–1392 critical care setting 347–353
signalment 284 cough albumin 349
treatment and prognosis 285 canine chronic bronchitis 305–310 analgesia 351–352
contact dermatitis 1414–1415, 1415 cardiovascular disease 120 assessment 348
continuous common source epidemic feline bronchial asthma 297–298, 303 bandage and wound care 352
curves 835, 835 gastrointestinal imaging 478 blood pressure and perfusion 349
continuous positive airway heart failure 194 cardiac function 349
pressure (CPAP) 388, respiratory pattern‐based approach client communication 348
395–396, 402 to dyspnea 290–291 coagulation 350
continuous renal replacement therapy valvular heart disease 246–247 drug metabolism and dosage 351
(CRRT) 1098, 1150, 1175–1176 cough‐drop syndrome 306 electrolyte and acid–base
continuous spontaneous ventilation COX/COX‐2 see cyclooxygenase balance 350
(CSV) 394 Coxiella burnetii see Q fever euthanasia 352
contractility CPA see cardiopulmonary arrest fluid therapy 347–349
canine myocardial disease 253–254 CPAP see continuous positive airway gastrointestinal motility and
cardiogenic shock 418 pressure integrity 351
heart failure 177 CPD see central pontine demyelination glucose 350
hypothermia 433 cPL see canine pancreatic lipase history 348
contrast radiography CPP see cerebral perfusion pressure immune status and antibiotic
esophageal disorders 558, 561–562 CPR see cardiopulmonary resuscitation coverage 351
gastrointestinal imaging CPSS see congenital portosystemic mentation and intracranial
469–471, 470, 480–483, 481, shunts pressure 347, 350
490–491, 491, 499 CPV‐2 see canine parvovirus type 2 motility disorders 571–572
motility disorders 564–565, 572, crackles nursing care and patient
573, 576–577 cardiovascular disease 125 mobility 352
COP see colloid oncotic/osmotic pleural effusion 335 nutrition 351
pressure respiratory pattern‐based approach oncotic pull 349
copper storage diseases to dyspnea 289, 292 oxygenation and ventilation 350
canine inflammatory liver cranberry extract (CE) 1194 physical examination 347–348
disease 696–697, 701 cranial nerves record keeping 348
cirrhosis 709 cranial nerves IX, X, and XII 739 red blood cell and hemoglobin
metabolic diseases 681–683 facial and trigeminal neurons concentration 350–351
corneal tumors 1261–1262 738–739 referral 348–349